Dennis M. Lanfear - 30 Dec 2022 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
President & CEO, Director
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Dennis M. Lanfear
Issuer symbol
CHRS
Transactions as of
30 Dec 2022
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 17:44:20 UTC
Previous filing
06 Jan 2022
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Gift $0 -4,000 -0.92% $0.000000 432,684 30 Dec 2022 By Trust F1
holding CHRS Common Stock 579,508 30 Dec 2022 Direct F2
holding CHRS Common Stock 86,965 30 Dec 2022 By LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
F2 Includes 86,250 restricted stock units.
F3 These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.